ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,567.19
1.06%
Dow Jones
39,375.87
0.17%
US Dollar vs MXN
18.1093
0.00%
Brent Oil
86.775
0.00%
Bitcoin
56,538.98
-0.19%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSXV
  6. (IMV)

  7. (IMV) Noticias

IMV

(IMV)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSXV:IMV
FechaHoraFuenteTítuloSímboloCompañía
26/08/201413:25PR Newswire (Canada)IIROC Trading Resumption - IMVTSXV:IMV
26/08/201413:25PR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - IMVTSXV:IMV
26/08/201407:16PR Newswire (Canada)IIROC Trading Halt - IMVTSXV:IMV
26/08/201407:16PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IMVTSXV:IMV
11/06/201408:18Marketwired CanadaImmunovaccine Appoints Marc Mansour as Chief Executive OfficerTSXV:IMV
02/06/201407:05MarketwiredImmunovaccine Reports Promising Clinical Activity for Novel T Cell Activating Immunotherapy DPX-Survivac at ASCO 2014TSXV:IMV
28/05/201416:05MarketwiredImmunovaccine Announces Financial Results for Quarter Ended March 31, 2014TSXV:IMV
20/05/201407:05MarketwiredImmunovaccine's Novel Immunotherapy Triggers Partial Response & Generates Potent Immune Responses in Ovarian Cancer Clinical ...TSXV:IMV
12/05/201416:31Marketwired CanadaImmunovaccine Clarifies May 12, 2014 Trading ActivityTSXV:IMV
07/05/201409:42Marketwired CanadaImmunovaccine Announces Withdrawal of Preliminary ProspectusTSXV:IMV
06/05/201414:16Marketwired CanadaImmunovaccine Announces Overnight Marketed Equity FinancingTSXV:IMV
24/04/201407:05MarketwiredImmunovaccine Announces Results of 2014 Annual General MeetingTSXV:IMV
08/04/201407:05MarketwiredImmunovaccine's DepoVax(TM) Technology Underpins New Experimental Therapy for Cervical, Head and Neck CancersTSXV:IMV
07/04/201407:05Marketwired CanadaImmunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer Vaccine Combination Therapies in Presentation at the 2014 AAC...TSXV:IMV
03/04/201407:05MarketwiredImmunovaccine to Present Data on Cancer Vaccine Combination Therapies at the 2014 AACR Annual MeetingTSXV:IMV
01/04/201407:05MarketwiredImmunovaccine and Pfenex Report Positive Results from Single Dose Anthrax Vaccine StudiesTSXV:IMV
17/03/201407:05Marketwired CanadaImmunovaccine Announces 2013 Year-End ResultsTSXV:IMV
20/01/201407:07MarketwiredLlew Keltner, US Biotech Industry Adviser, Joins Board of ImmunovaccineTSXV:IMV
20/01/201407:05MarketwiredImmunovaccine Grants Stock OptionsTSXV:IMV
09/01/201407:05MarketwiredImmunovaccine to Present at 6th Annual Biotech Showcase ConferenceTSXV:IMV
16/12/201307:05MarketwiredImmunovaccine Elects Marc Mansour, Ph.D. to Board of DirectorsTSXV:IMV
29/11/201307:05MarketwiredImmunovaccine Announces Financial Results for Quarter Ended September 30, 2013TSXV:IMV
21/11/201306:05Marketwired CanadaImmunovaccine Raises $4.2 Million in Private PlacementTSXV:IMV
28/10/201307:05Marketwired CanadaImmunovaccine Announces a Non-Brokered Private Placement of $3.2 millionTSXV:IMV
11/10/201315:54Marketwired CanadaImmunovaccine Retains B & D Capital Partners For Strategic Investor Relations ServicesTSXV:IMV
09/09/201307:17Marketwired CanadaImmunovaccine Reports Positive Results from Two Anthrax StudiesTSXV:IMV
03/09/201315:05Marketwired CanadaImmunovaccine Announces Management Team ChangesTSXV:IMV
29/08/201316:05Marketwired CanadaImmunovaccine Announces Financial Results for the Quarter Ended June 30, 2013TSXV:IMV
02/08/201308:27Marketwired CanadaImmunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax(TM) PlatformTSXV:IMV
15/07/201307:05Marketwired CanadaImmunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-SurvivacTSXV:IMV
 Showing the most relevant articles for your search:TSXV:IMV

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
NASDAQ
TSLA
Tesla
NYSE
CVX
Chevron
NASDAQ
AAPL
Apple
AMEX
XLV
Health Care Select Sector
FX
EURUSD
Euro vs US Dollar
COIN
SOLUSD
Solana
NYSE
NKE
Nike
USOTC
DTEGY
Deutsche Telekom (QX)
SPI
SP500
S&P 500
COIN
BTCUSD
Bitcoin
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
NYSE
BAC
Bank of America
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados